Literature DB >> 19929612

Bioinformatics for protein biomarker panel classification: what is needed to bring biomarker panels into in vitro diagnostics?

Xavier Robin1, Natacha Turck, Alexandre Hainard, Frédérique Lisacek, Jean-Charles Sanchez, Markus Müller.   

Abstract

A large number of biomarkers have been discovered over the past few years using proteomics techniques. Unfortunately, most of them are neither specific nor sensitive enough to be translated into in vitro diagnostics and routine clinical practice. From this observation, the idea of combining several markers into panels to improve clinical performances has emerged. In this article, we present a discussion of the bioinformatics aspects of biomarker panels and the concomitant challenges, including high dimensionality and low patient number and reproducibility.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19929612     DOI: 10.1586/epr.09.83

Source DB:  PubMed          Journal:  Expert Rev Proteomics        ISSN: 1478-9450            Impact factor:   3.940


  23 in total

Review 1.  Emerging Role of MicroRNAs as Liquid Biopsy Biomarkers in Gastrointestinal Cancers.

Authors:  Kunitoshi Shigeyasu; Shusuke Toden; Timothy J Zumwalt; Yoshinaga Okugawa; Ajay Goel
Journal:  Clin Cancer Res       Date:  2017-01-31       Impact factor: 12.531

2.  A method of gene expression data transfer from cell lines to cancer patients for machine-learning prediction of drug efficiency.

Authors:  Nicolas Borisov; Victor Tkachev; Maria Suntsova; Olga Kovalchuk; Alex Zhavoronkov; Ilya Muchnik; Anton Buzdin
Journal:  Cell Cycle       Date:  2018-01-17       Impact factor: 4.534

3.  Integrated proteomic profiling of cell line conditioned media and pancreatic juice for the identification of pancreatic cancer biomarkers.

Authors:  Shalini Makawita; Chris Smith; Ihor Batruch; Yingye Zheng; Felix Rückert; Robert Grützmann; Christian Pilarsky; Steven Gallinger; Eleftherios P Diamandis
Journal:  Mol Cell Proteomics       Date:  2011-06-07       Impact factor: 5.911

4.  Pancreatic carcinoma, pancreatitis, and healthy controls: metabolite models in a three-class diagnostic dilemma.

Authors:  Alexander Benedikt Leichtle; Uta Ceglarek; Peter Weinert; Christos T Nakas; Jean-Marc Nuoffer; Julia Kase; Tim Conrad; Helmut Witzigmann; Joachim Thiery; Georg Martin Fiedler
Journal:  Metabolomics       Date:  2012-11-06       Impact factor: 4.290

5.  Chaperone probes and bead-based enhancement to improve the direct detection of mRNA using silicon photonic sensor arrays.

Authors:  Jared T Kindt; Ryan C Bailey
Journal:  Anal Chem       Date:  2012-08-31       Impact factor: 6.986

6.  Serum amino acid profiles and their alterations in colorectal cancer.

Authors:  Alexander Benedikt Leichtle; Jean-Marc Nuoffer; Uta Ceglarek; Julia Kase; Tim Conrad; Helmut Witzigmann; Joachim Thiery; Georg Martin Fiedler
Journal:  Metabolomics       Date:  2011-09-16       Impact factor: 4.290

7.  Identification of Putative Early Atherosclerosis Biomarkers by Unsupervised Deconvolution of Heterogeneous Vascular Proteomes.

Authors:  Sarah J Parker; Lulu Chen; Weston Spivia; Georgia Saylor; Chunhong Mao; Vidya Venkatraman; Ronald J Holewinski; Mitra Mastali; Rakhi Pandey; Grace Athas; Guoqiang Yu; Qin Fu; Dana Troxlair; Richard Vander Heide; David Herrington; Jennifer E Van Eyk; Yue Wang
Journal:  J Proteome Res       Date:  2020-04-07       Impact factor: 4.466

Review 8.  Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic.

Authors:  Harald Hampel; Sid E O'Bryant; José L Molinuevo; Henrik Zetterberg; Colin L Masters; Simone Lista; Steven J Kiddle; Richard Batrla; Kaj Blennow
Journal:  Nat Rev Neurol       Date:  2018-11       Impact factor: 42.937

9.  Post-acute brain injury urinary signature: a new resource for molecular diagnostics.

Authors:  Andrew K Ottens; Jillian E Stafflinger; Hailey E Griffin; Richard D Kunz; David X Cifu; Janet P Niemeier
Journal:  J Neurotrauma       Date:  2014-03-06       Impact factor: 5.269

Review 10.  Using bacterial biomarkers to identify early indicators of cystic fibrosis pulmonary exacerbation onset.

Authors:  Geraint B Rogers; Lucas R Hoffman; Matt W Johnson; Nicole Mayer-Hamblett; Jürgen Schwarze; Mary P Carroll; Kenneth D Bruce
Journal:  Expert Rev Mol Diagn       Date:  2011-03       Impact factor: 5.225

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.